Skip to Content
Merck

Key Documents

View All Documentation

Skip To

PHR3402

Supelco

Argatroban monohydrate

Synonym(s):

(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic Acid, Argipidine, MQPA

Sign Into View Organizational & Contract Pricing

Select a Size

25 MG
CA$273.98
100 MG
CA$750.87
200 MG
CA$1,287.50

CA$273.98

Please contact Customer Service for Availability
Request a Bulk Order

Select a Size

Change View
25 MG
CA$273.98
100 MG
CA$750.87
200 MG
CA$1,287.50

About This Item

Empirical Formula (Hill Notation):
C23H36N6O5S · H2O
CAS Number:
141396-28-3
Molecular Weight:
526.65
UNSPSC Code:
41116107
NACRES:
NA.24

CA$273.98

Please contact Customer Service for Availability
Request a Bulk Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

certified reference material
pharmaceutical secondary standard

Quality Level

300

Agency

traceable to USP 1042408

CofA

current certificate can be downloaded

packaging

pkg of 500 mg

application(s)

pharmaceutical

storage temp.

2-8°C

SMILES string

[S](=O)(=O)(NC(CCCNC(=N)N)C(=O)N3[C@H](C[C@@H](CC3)C)C(=O)O)c1c2c(ccc1)CC(CN2)C.O

InChI

1S/C23H36N6O5S.H2O/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19;/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26);1H2/t14-,15?,17?,18-;/m1./s1

InChI key

AIEZTKLTLCMZIA-LINCPPCXSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
KVGLA3TTT1KVVLA3TTT1KVGLA3THH1
Durapore® 0,22 µm, Capsule Opticap® XLT Opticap® XLT 30, inlet connection diam. 1.5 in., cartridge nominal length 30 in. (75 cm)

KVGLA3TTH1

Durapore® 0,22 µm, Capsule Opticap® XLT

Durapore® 0,22 µm, Capsule Opticap® XLT Opticap® XLT 30, inlet connection diam. 1.5 in., cartridge nominal length 30 in. (75 cm)

KVGLA3TTT1

Durapore® 0,22 µm, Capsule Opticap® XLT

Durapore® 0,1 µm, Capsule Opticap® XLT Opticap® XLT 30, inlet connection diam. 1.5 in., cartridge nominal length 30 in. (75 cm)

KVVLA3TTT1

Durapore® 0,1 µm, Capsule Opticap® XLT

Durapore® 0,22 µm, Capsule Opticap® XLT Opticap® XLT 30, inlet connection diam. 5/8 in., cartridge nominal length 30 in. (75 cm)

KVGLA3THH1

Durapore® 0,22 µm, Capsule Opticap® XLT

pore size

0.22 μm

pore size

0.22 μm

pore size

0.1 μm

pore size

0.22 μm

technique(s)

sterile filtration: suitable

technique(s)

sterile filtration: suitable

technique(s)

sterile filtration: suitable

technique(s)

sterile filtration: suitable

filtration area

2.1 m2

filtration area

2.1 m2

filtration area

2.1 m2

filtration area

2.1 m2

product line

Opticap® XLT 30

product line

Opticap® XLT 30

product line

Opticap® XLT 30

product line

Opticap® XLT 30

material

PVDF , polypropylene housing, polypropylene vent cap, silicone seal, polypropylene support

material

PVDF , polypropylene , polypropylene housing, polypropylene support, polypropylene vent cap, silicone seal

material

PVDF , polypropylene , polypropylene housing, polypropylene support, polypropylene vent cap, silicone seal

material

PVDF , polypropylene , polypropylene housing, polypropylene support, polypropylene vent cap, silicone seal

sterility

non-sterile

sterility

non-sterile

sterility

non-sterile

sterility

non-sterile

General description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Application

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Biochem/physiol Actions

Argatroban is a potent, selective, direct inhibitor of thrombin and a clinical anticoagulant.
Argatroban is a potent, seletive, univalent direct inhibitor of thrombin. It directly inhibits thrombin by binding only to its active site (thus univalent) as compared to Bivalent DTIs (hirudin and analogs) which bind both to the active site and exosite 1.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

    • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Controlling loading and optical properties of gold nanoparticles on liposome membranes
    Sau TK, et al.
    Colloids and Surfaces. A, Physicochemical and Engineering Aspects, 342(1-3), 92-96 (2009)
    Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents
    Kim TW, et al.
    Pharmaceutical Research, 18(1), 54-60 (2001)
    Enhanced intrapulmonary delivery of anticancer siRNA for lung cancer therapy using cationic ethylphosphocholine-based nanolipoplexes
    Shim G, et al.
    Molecular Therapy, 21(4), 816-824 (2013)
    Lipid nanoparticles for delivery of messenger RNA to the back of the eye
    Patel S, et al.
    J. Controlled Release, 303, 91-100 (2019)
    Kabir H Biswas et al.
    Langmuir : the ACS journal of surfaces and colloids, 34(4), 1775-1782 (2017-12-28)
    The pathway of vesicle adsorption onto a solid support depends on the material composition of the underlying support, and there is significant interest in developing material-independent strategies to modulate the spectrum of vesicle-substrate interactions on a particular surface. Herein, using
    View All Related Papers

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service